Navigation Links
AlphaVax Announces Results From Phase 1 Influenza Vaccine Clinical Trial
Date:10/31/2007

RESEARCH TRIANGLE PARK, N.C., Oct. 31 /PRNewswire/ -- AlphaVax, Inc. announced today that it has concluded a phase 1 clinical trial in 216 volunteers of an influenza vaccine based on its proprietary replicon vector platform. This study was designed to further assess the properties of this unique vector system as well as the feasibility of its application to influenza vaccines.

The study was a placebo-controlled, randomized, double-blind trial in healthy adults, 18-40 years old, which evaluated the safety and humoral and cellular immune responses after one or two inoculations. The replicon vector expressed the hemagglutinin (HA) gene derived from the A/Wyoming (H3N2) strain of influenza virus. The vaccine was administered either subcutaneously or intramuscularly at two dosage levels, and was found to be safe and well tolerated irrespective of the route or the dose given.

Both antibody and T cell responses were efficiently stimulated and persisted for the duration of the four-month study. Among volunteers with prevaccination influenza antibody titers (measured by hemagglutination inhibition, or "HI") that were below levels thought to be protective, 77% and 80% of these individuals receiving a single low or high dose, respectively, responded with protective HI antibody titers. A second immunization in these individuals increased seroprotective responses to 86% for both dosage levels. A rapid and dose-dependent T cell response (defined in antigen-specific IFN-gamma ELISPOT assays) was also observed and remained significantly elevated for at least four months. A second immunization extended the duration, but not the magnitude of these T cell responses. For both antibody and cellular responses, there was no significant difference observed between subcutaneous and intramuscular vaccinations.

"We were pleased to see the balanced immune response consisting of both humoral and cellular responses", said Dr. Jonathan Smith, CSO at AlphaVax. "Comparable
'/>"/>

SOURCE AlphaVax, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 28, 2015 According to a ... (Breast, Lung, Prostate) Type (Protein & Genetic Biomarkers) Profiling ... Prognostic) & Geography - Global Forecast to 2020", published ... reach around 17,689.0 Million USD by 2020 at a ... to 2020. Browse 191 Tables and ...
(Date:8/28/2015)... Aug. 28, 2015 Research ... of the "Investigation Report on China,s Tobramycin Market, ... is a traditional antibiotic whose eye drop and ointment ... of potential infection or inflammation caused by eye infection. ... are able to produce tobramycin, among which the ...
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on ... their offering. Developed by Novo Nordisk, ... is an important drug for the treatment of ... a fast- acting insulin analog, starts working fast ...
Breaking Medicine Technology:Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 5Investigation Report on China's Tobramycin Market, 2015-2019 2China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2
... ISPE announced today that it has brought ... pharmaceutical industry leaders to be plenary speakers at the ... Baltimore, Maryland, USA on 4 – 5 June 2012. ... the key CGMP issues affecting the pharmaceutical industry today.  ...
... Pharmaceuticals, Inc. (PINKSHEETS: GMPM.PK) a marketing and product ... everyday health and wellness, announced this afternoon, the ... for the Company,s 17-gram Gamma Energy GEL.  The ... Gamma will support sales with point of purchase ...
Cached Medicine Technology:Global Regulatory and Pharmaceutical Industry Leaders to Appear as Plenary Speakers at Joint FDA-ISPE CGMP Conference 2Gamma Pharmaceuticals, Inc. Announces Distribution Agreement for New York Tri-state Area and Purchase Order for Gamma Energy GEL™ 2Gamma Pharmaceuticals, Inc. Announces Distribution Agreement for New York Tri-state Area and Purchase Order for Gamma Energy GEL™ 3
(Date:8/30/2015)... , ... August 30, 2015 , ... ... platforms and devices, today announced it is a Silver Sponsor of the Digital ... Sky City Convention Centre in Auckland, NZ. Throughout the event, AvePoint will showcase ...
(Date:8/30/2015)... ... August 30, 2015 , ... InHealth Media ( ... new Global Communications Director for InHealth Media. Mr. Spector comes with a ... 16 years doing on-air television, producing shows, on air-radio and media relations. ...
(Date:8/30/2015)... ... August 30, 2015 , ... Nutritional Products ... lead the expansion of global cosmeceutical and skin care brands. Mr. Fernandez ... the last 25 years working in operations, purchasing and management for some of ...
(Date:8/29/2015)... ... ... Rio Salado College President Chris Bustamante announced on Aug. 19 ... Initiatives and Information Services. O’Shea, who has served Rio Salado for the last two ... through innovative technologies and strategies. , “I am very proud to be able to ...
(Date:8/29/2015)... PA (PRWEB) , ... August 29, 2015 , ... On ... the Mesothelioma Applied Research Foundation (Meso Foundation) will present an educational program ... at 7:00 PM and lasts through 9:30 PM (doors open at 6:45pm) at Calvary ...
Breaking Medicine News(10 mins):Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 2Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 3Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 4Health News:InHealth Media Appoints New Global Communications Director 2Health News:NPI Executive Vice President Leads Cosmeceutical Expansion 2Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:Mesothelioma Applied Research Foundation to Hold Educational Class About Asbestos and Mesothelioma Prevention 2
... Snowblowers are a great tool for those who get lots ... your driveway clear, they can also leave your fingers in ... surgeon from Loyola University Health System in Chicago says that ... amputations and extensive rehabilitation. "Every winter, we get three or ...
... Dotinga HealthDay Reporter , FRIDAY, Dec. 31 (HealthDay ... at an increasingly young age, with about one-third of them ... old, researchers have found. There are some caveats about ... were born about a decade ago. And it,s not clear ...
... Gordon HealthDay Reporter , THURSDAY, Dec. 30 (HealthDay ... holiday parties, hangovers are not uncommon. And while folk remedies ... the misery of a hangover the morning after are time ... of a hangover -- drinking too much alcohol -- is ...
... , , , , , , , ... , , , ... can be. Now a study led by researchers... , Click here for more information. ... , , , , , , ...
... Reporter , THURSDAY, Dec. 29 (HealthDay News) -- Following mothers, ... major health crisis. Fears of the H1N1 flu virus ... fearing a widespread outbreak caused by short supplies of the ... experts believe that,s because more people than ever before regularly ...
... By Ellin Holohan HealthDay Reporter , WEDNESDAY, Dec. ... may lead to less satisfying marriages because couples can fail ... new research suggests. The study, done at Brigham Young ... sex while they were dating were more likely to communicate, ...
Cached Medicine News:Health News:In U.S., Obesity Afflicts Even Some of the Tiniest Tots 2Health News:In U.S., Obesity Afflicts Even Some of the Tiniest Tots 3Health News:'Hair Of The Dog' No Hangover Cure, Say Experts 2Health News:'Hair Of The Dog' No Hangover Cure, Say Experts 3Health News:Consistent exercise associated with lower risk of colon cancer death 2Health News:Consistent exercise associated with lower risk of colon cancer death 3Health News:Hand-Washing May Have Kept Flu at Bay 2Health News:Hand-Washing May Have Kept Flu at Bay 3Health News:Delaying Sex Might Strengthen Marriage 2Health News:Delaying Sex Might Strengthen Marriage 3
... System is an automated multiplexing platform that ... detection, pathogen sequence detection and pharmacogenetics applications. ... applied to an open and flexible electronic ... reused until all tests sites have been ...
Cable connections for 5 different adapters: Storz, ACMI, Pentax, Wolf and Olympus....
... Mark The X & Y Coordinates At The ... Alignment. 11mm Inner Diameter & 13mm Outer Diameter ... Guess Work Associated With Hand-Held Markers By Mounting ... Housing To Ensure A More Perfect Mark. , ...
... • V-shaped bottom allows easy withdrawal ... facilitate pour-out ,• Nesting ring allows ... Basin designed for 4, 8, and 12 ... bottom permits withdrawal of practically all of ...
Medicine Products: